Targeting Innate Immunity in Breast Cancer Therapy: A Narrative Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Innate Immunity in Breast Cancer Therapy: A Narrative Review
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-01
DOI
10.3389/fimmu.2021.771201
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy
- (2021) Robyn V. Broad et al. BRITISH JOURNAL OF CANCER
- The Promise and Challenges of Cyclic Dinucleotides as Molecular Adjuvants for Vaccine Development
- (2021) Hongbin Yan et al. Vaccines
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- STAT3 Inhibits CD103+ cDC1 Vaccine Efficacy in Murine Breast Cancer
- (2020) Taylor T. Chrisikos et al. Cancers
- A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy
- (2020) Di-Wei Zheng et al. Nature Communications
- IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
- (2020) Margaux Hubert et al. Science Immunology
- Understanding the Role of Innate Immune Cells and Identifying Genes in Breast Cancer Microenvironment
- (2020) Israa Shihab et al. Cancers
- RIG-1-Like Receptor Activation Synergizes With Intratumoral Alpha Radiation to Induce Pancreatic Tumor Rejection, Triple-Negative Breast Metastases Clearance, and Antitumor Immune Memory in Mice
- (2020) Vered Domankevich et al. Frontiers in Oncology
- Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy
- (2020) Leila Motedayen Aval et al. Journal of Clinical Medicine
- Inflammatory Breast Cancer Promotes Development of M2 Tumor-associated Macrophages and Cancer Mesenchymal Cells Through a Complex Cytokine Network
- (2019) Amanda Valeta-Magara et al. CANCER RESEARCH
- Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy
- (2019) Min Luo et al. JOURNAL OF CONTROLLED RELEASE
- STING pathway agonism as a cancer therapeutic
- (2019) Blake A. Flood et al. IMMUNOLOGICAL REVIEWS
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- Harnessing RIG-I and intrinsic immunity in the tumor microenvironment for therapeutic cancer treatment
- (2018) David L. Elion et al. Oncotarget
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
- (2018) Flávia Castro et al. Frontiers in Immunology
- Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors
- (2018) Erika J. Crosby et al. OncoImmunology
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
- (2017) Abhishek D. Garg et al. IMMUNOLOGICAL REVIEWS
- cGAS is essential for the antitumor effect of immune checkpoint blockade
- (2017) Hua Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breast cancer genomics and immuno-oncological markers to guide immune therapies
- (2017) D. Hammerl et al. SEMINARS IN CANCER BIOLOGY
- The anticancer functions of RIG-I–like receptors, RIG-I and MDA5, and their applications in cancer therapy
- (2017) Yuanbing Wu et al. Translational Research
- The relationship between breast cancer molecular subtypes and mast cell populations in tumor microenvironment
- (2017) Anna Glajcar et al. VIRCHOWS ARCHIV
- Mechanism of immune evasion in breast cancer
- (2017) Mozhi Wang et al. OncoTargets and Therapy
- A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice
- (2017) Jeremy B. Foote et al. Cancer Immunology Research
- The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression
- (2017) Julia M. Weiss et al. OncoImmunology
- Targeting Inflammation in Cancer Prevention and Therapy
- (2016) J. Todoric et al. Cancer Prevention Research
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- Vaccine adjuvants as potential cancer immunotherapeutics
- (2016) Burcu Temizoz et al. INTERNATIONAL IMMUNOLOGY
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- TLR-activated plasmacytoid dendritic cells inhibit breast cancer cell growth in vitro and in vivo
- (2016) Jing Wu et al. Oncotarget
- Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
- (2016) H. Raza Ali et al. PLOS MEDICINE
- Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer
- (2015) Parvin Forghani et al. BREAST CANCER RESEARCH AND TREATMENT
- STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice
- (2015) Zili Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CCL2 and CCL5 Are Novel Therapeutic Targets for Estrogen-Dependent Breast Cancer
- (2015) S. Svensson et al. CLINICAL CANCER RESEARCH
- Toll-like receptor 7/8 agonist, R848, exhibits antitumoral effects in a breast cancer model
- (2015) TAO YIN et al. Molecular Medicine Reports
- Control of adaptive immunity by the innate immune system
- (2015) Akiko Iwasaki et al. NATURE IMMUNOLOGY
- Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
- (2015) J. Rautela et al. Cancer Immunology Research
- Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs
- (2015) Kea Martin et al. Frontiers in Immunology
- G-CSF regulates macrophage phenotype and associates with poor overall survival in human triple-negative breast cancer
- (2015) Maija Hollmén et al. OncoImmunology
- RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8+ T cells
- (2014) P Duewell et al. CELL DEATH AND DIFFERENTIATION
- C-Type Lectin-like Receptor LOX-1 Promotes Dendritic Cell-Mediated Class-Switched B Cell Responses
- (2014) HyeMee Joo et al. IMMUNITY
- STING Ligand c-di-GMP Improves Cancer Vaccination against Metastatic Breast Cancer
- (2014) D. Chandra et al. Cancer Immunology Research
- Nod-Like Receptors: Key Molecular Switches in the Conundrum of Cancer
- (2014) Andrew Kent et al. Frontiers in Immunology
- Monocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activator
- (2013) Philip Vlaicu et al. BMC CANCER
- TLR agonists: our best frenemy in cancer immunotherapy
- (2013) Sabina Kaczanowska et al. JOURNAL OF LEUKOCYTE BIOLOGY
- IFN-γ Rα Is a Key Determinant of CD8+ T Cell-Mediated Tumor Elimination or Tumor Escape and Relapse in FVB Mouse
- (2013) Maciej Kmieciak et al. PLoS One
- MHC Class II Antigen Presentation by Dendritic Cells Regulated through Endosomal Sorting
- (2013) T. ten Broeke et al. Cold Spring Harbor Perspectives in Biology
- The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
- (2012) Catharina Medrek et al. BMC CANCER
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Signaling in Innate Immunity and Inflammation
- (2012) K. Newton et al. Cold Spring Harbor Perspectives in Biology
- The role of Type I interferons in immunoregulation of breast cancer metastasis to the bone
- (2012) Clare Y. Slaney et al. OncoImmunology
- Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer
- (2011) Touko Inao et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung
- (2011) Zvi Granot et al. CANCER CELL
- Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions
- (2011) Damya Laoui et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Heterogeneity in breast cancer
- (2011) Kornelia Polyak JOURNAL OF CLINICAL INVESTIGATION
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
- (2011) Sahar M.A. Mahmoud et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma
- (2011) Ahmad A. Tarhini et al. JOURNAL OF CLINICAL ONCOLOGY
- Innate Immune Cells in Breast Cancer – From Villains to Heroes?
- (2011) Tim Kees et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- TLR signalling regulated antigen presentation in dendritic cells
- (2010) Colin Watts et al. CURRENT OPINION IN IMMUNOLOGY
- Inflammatory cytokines as a third signal for T cell activation
- (2010) Julie M Curtsinger et al. CURRENT OPINION IN IMMUNOLOGY
- “Hard” and “soft” lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy
- (2010) Federico Garrido et al. INTERNATIONAL JOURNAL OF CANCER
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Regulation of Adaptive Immunity by the Innate Immune System
- (2010) A. Iwasaki et al. SCIENCE
- 5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
- (2008) Hendrik Poeck et al. NATURE MEDICINE
- Macrophage polarization in tumour progression
- (2008) Antonio Sica et al. SEMINARS IN CANCER BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search